Medicine recalls
|
| |
| Batch recall of Atama Capsules 10mg |
| |
The Department of Health (DH) today (26 July) endorsed a licensed drug wholesaler, namely I & C (HONG KONG) LIMITED (I & C), to recall one batch (batch number: 1300360) of Atama Capsules 10mg (Hong Kong Registration number: HK-66751), from the market as a precautionary measure due to potential quality issue.
The DH received notification from I & C that the overseas manufacturer of the product is recalling the above batch due to retained sample retesting showed out of specification result. As a precautionary measure, I & C is voluntarily recalling the above batch from the market.
The above product, containing atomoxetine hydrochloride, is a prescription medicine used for the treatment of attention deficit/hyperactivity disorder. According to I & C, the above batch of product has been imported into Hong Kong and supplied to Hospital Authority only.
I & C has set up a hotline (2891 0581) to answer related enquiries.
So far, the DH has not received any adverse reaction reports in connection with the above batch of product. The DH will closely monitor the recall.
Patients who are taking the above product should not stop taking the medicine, but should consult their healthcare professionals as soon as possible for appropriate arrangements.
End/Friday, July 26, 2024
|
| |
|
